Supporting SDGs 3 (good health and well-being), 6 (clean water and sanitation) and 12 (responsible consumption and production), this research investigates the occurrence and diversity of antibiotic resistance genes, from water source, through treatment plants, to tap in the Pearl River Delta region, South China.
Elsevier,

Seminars in Oncology Nursing, Volume 34, Issue 1, February 2018, Pages 52-59.

Contributing to SDG 3 (good health and well-being) and SDG 10 (reduced inequalities), this article discusses integrating sexual and gender minority identities with cancer survivor identities and the coordination of medical care.
The Lancet Report - Stillbirth in low and middle-income countries
Highlighting the data behind stillbirths to bring about change, this article and video supports SDG 3. 2.6 million babies worldwide are stillborn each year. The majority of these are preventable. The Lancet partnered with the London School of Hygiene & Tropical Medicine to find solutions to end this silent scandal.
Elsevier,

Journal of Ethnopharmacology, Volume 210, 10 January 2018, Pages 372-385.

Contributing to SDGs 3 (Good health and Well-being) and 15 (Life on Land), this Elsevier Atlas Award winning article seeks to scientifically validate traditional medicinal plant practices in the Peruvian Amazon.
This study performed a retrospective study on the hormonal and metabolic effects of cross-sex hormone therapy (CSHT) in a small cohort of transgender patients. Research findings contribute to SDG 3 (good health and well-being) and SDG 10 (reduced inequalities).
Elsevier,

Microchemical Journal, Volume 136, January 2018, Pages 25-39.

Focussing on SDGs 3 (Good Health and Well-being), 12 (Responsible Consumption and Production), 14 (Life Below Water) and 15 (Life on Land), this Elsevier Atlas Award winning review explores the effects of antibiotics on natural microbial communities in soil and water systems.
SDG 3.3 sets a target of combating viral hepatitis. Sub-Saharan Africa carries a substantial portion of the global burden of viral hepatitis. Countries in the region face unique challenges, with the development of elimination strategies often hindered by a lack of good quality data. This paper outlines the current status of hepatitis C in sub-Saharan Africa and provides expert recommendations from across the region, including simplified diagnostic and treatment algorithms for use in low-resource settings.
Three or more cups of coffee daily halves mortality risk in patients with both HIV and HCV. This finding is based on a large nation-wide study in France. This is relevant to SDG 3 and specifically the targets concerned with the reduction of infection diseases, like hepatitis C (HCV).
HIV Rapid Test being administered (Equality Michigan viaWikimedia Commons)
Patients in China can face long delays in completing their testing and initiating treatment when newly diagnosed with HIV. This study aimed to improve linkage to care by assessing the effectiveness of an intervention involving rapid point-of-care testing, trialled in Guangxi Zhuang Autonomous Region, south China. The intervention increased the number of patients starting treatment and reduced mortality. However, difficulties in ensuring patients remained in the care cascade were noted and highlights the challenges China faces in meeting the SDG 3 goals.
SDG 3.3 sets a target of combating viral hepatitis. Sub-Saharan Africa carries a substantial portion of the global burden of viral hepatitis. Countries in the region face unique challenges, with the development of elimination strategies often hindered by a lack of good quality data. This paper outlines the current status of hepatitis B in sub-Saharan Africa and provides expert recommendations from across the region, including simplified diagnostic and treatment algorithms for use in low-resource settings.

Pages